THE HISTONE METHYLTRANSFERASES MLL2 AND MLL4 CONSTITUTE NOVEL NF-E2 TARGET GENES

被引：0
|
作者：
Koellerer, C. [1 ]
Pahl, L. [1 ]
Wehrle, J. [1 ]
机构：
[1] Univ Med Ctr Freiburg, Clin Res Ctr, Dept Hematol Oncol, Sect Mol Hematol, Freiburg, Germany
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S711
引用
收藏
页码：252 / 253
页数：2
相关论文
共 50 条
  • [21] Pax6 associates with H3K4-specific histone methyltransferases Mll1, Mll2, and Set1a and regulates H3K4 methylation at promoters and enhancers
    Sun, Jian
    Zhao, Yilin
    McGreal, Rebecca
    Cohen-Tayar, Yamit
    Rockowitz, Shira
    Wilczek, Carola
    Ashery-Padan, Ruth
    Shechter, David
    Zheng, Deyou
    Cvekl, Ales
    EPIGENETICS & CHROMATIN, 2016, 9
  • [22] The identification and characterization of MLL2, an epigenetic enzyme, as a novel tumor suppressor in melanoma
    Keung, Emily Z.
    Rai, Kunal
    Akdemir, Kadir C.
    Li, Liren
    Sharma, Sneha
    Axelrad, Bryce
    Chin, Lnda
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes
    Robert, I.
    Aussems, M.
    Keutgens, A.
    Zhang, X.
    Hennuy, B.
    Viatour, P.
    Vanstraelen, G.
    Merville, M-P
    Chapelle, J-P
    de Leval, L.
    Lambert, F.
    Dejardin, E.
    Gothot, A.
    Chariot, A.
    ONCOGENE, 2009, 28 (13) : 1626 - 1638
  • [24] IMPACT OF HISTONE LYSINE METHYLTRANSFERASES SETDB1, SETD2, SUV39H1, MLL2, EZH2AND THEIR CORRESPONDING HISTONE MARKS IN PEDIATRIC ASTROCYTOMAS
    Klonou, A.
    Korkolopoulou, P.
    Gargalionis, A. N.
    Themistocleous, M.
    Sgouros, S.
    Papavassiliou, A. G.
    Piperi, C.
    NEURO-ONCOLOGY, 2019, 21 : 32 - 32
  • [25] Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes
    I Robert
    M Aussems
    A Keutgens
    X Zhang
    B Hennuy
    P Viatour
    G Vanstraelen
    M-P Merville
    J-P Chapelle
    L de Leval
    F Lambert
    E Dejardin
    A Gothot
    A Chariot
    Oncogene, 2009, 28 : 1626 - 1638
  • [26] CHARACTERIZATION OF JMJD1C AND JMJD2C AS NOVEL NF-E2 TARGET GENES
    Peeken, J.
    Wehrle, J.
    Gothwal, M.
    Seeger, T.
    Pahl, H.
    HAEMATOLOGICA, 2013, 98 : 106 - 107
  • [27] Report of the First Clinical Case of a Moroccan Kabuki Patient with a Novel MLL2 Mutation
    Ratbi, I.
    Fejjal, N.
    Micale, L.
    Augello, B.
    Fusco, C.
    Lyahyai, J.
    Merla, G.
    Sefiani, A.
    MOLECULAR SYNDROMOLOGY, 2013, 4 (03) : 152 - 156
  • [28] MLL2 histone methylase in estrogen dependent trans-activation of high density lipoprotein receptors
    Mandal, Subhrangsu S.
    Ansari, Khairul I.
    FASEB JOURNAL, 2009, 23
  • [29] Deletion of KDM6A, a Histone Demethylase Interacting with MLL2, in Three Patients with Kabuki Syndrome
    Lederer, Damien
    Grisart, Bernard
    Digilio, Maria Cristina
    Benoit, Valerie
    Crespin, Marianne
    Ghariani, Sophie Claire
    Maystadt, Isabelle
    Dallapiccola, Bruno
    Verellen-Dumoulin, Christine
    AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 90 (01) : 119 - 124
  • [30] MLL2 histone methylase in estrogen dependent trans-activation of high density lipoprotein receptors
    Mandal, Subhrangsu S.
    Ansari, Khairul I.
    FASEB JOURNAL, 2009, 23
12345